The Wolverine Stack is the most popular healing peptide blend — BPC-157 (10mg) and TB-500 (10mg) pre-mixed in a single 20mg vial. BPC-157 drives localized repair (angiogenesis, growth factors), TB-500 handles the systemic side (cell migration, actin remodeling). For the full mechanism breakdown and synergy research, see the Wolverine Stack Benefits Guide.
Research-context information only. The Wolverine stack is a research-peptide blend (containing BPC-157 and TB-500). Protocols, doses, and reactions reported below come from published research and self-reported community sources. This article reports what has been documented, not what should be done. Consult a licensed physician for personal medical decisions.
Research compounds without FDA approval. All protocols below are community-derived. This is not medical advice.
Wolverine Stack (BPC-157 + TB-500) Dosing Table
Match your vial size below — reconstitution and dose math update automatically.
Vials are labeled "10/10" — 10 mg BPC-157 + 10 mg TB-500 (20 mg total). Doses split evenly between the two.
| Dose | Syringe units | mL volume | Schedule |
|---|---|---|---|
| 500 mcg blend | 5 units | 0.05 mL | Daily SubQStandard (250mcg of each) |
| 1 mg blend | 10 units | 0.1 mL | Daily SubQLoading (500mcg of each) |
Math assumes U-100 insulin syringes (1 mL = 100 units). Verify your syringe matches before injecting. Round half-units to the nearest visible mark.
Vials are labeled "5/5" — 5 mg BPC-157 + 5 mg TB-500 (10 mg total). Doses split evenly between the two.
| Dose | Syringe units | mL volume | Schedule |
|---|---|---|---|
| 500 mcg blend | 5 units | 0.05 mL | Daily SubQStandard (250mcg of each) |
| 1 mg blend | 10 units | 0.1 mL | Daily SubQLoading (500mcg of each) |
Math assumes U-100 insulin syringes (1 mL = 100 units). Verify your syringe matches before injecting. Round half-units to the nearest visible mark.
Vials are labeled "20/20" — 20 mg BPC-157 + 20 mg TB-500 (40 mg total). Doses split evenly between the two.
| Dose | Syringe units | mL volume | Schedule |
|---|---|---|---|
| 500 mcg blend | 5 units | 0.05 mL | Daily SubQStandard (250mcg of each) |
| 1 mg blend | 10 units | 0.1 mL | Daily SubQLoading (500mcg of each) |
Math assumes U-100 insulin syringes (1 mL = 100 units). Verify your syringe matches before injecting. Round half-units to the nearest visible mark.
Quick Reference: Community Protocol
| Parameter | Community Protocol |
|---|---|
| Dose | 500 mcg total daily (250 mcg each peptide) |
| Route | Subcutaneous injection |
| Timing | AM, before food |
| Frequency | Every day |
| Cycle | 8 weeks on, 8 weeks off |
| Vial size | 20 mg (10mg BPC-157 + 10mg TB-500); 10 mg and 40 mg also sold |
| Reconstitution | 2 mL bacteriostatic water → 10 mg/mL (scale water with vial size) |
| Draw amount | 5 units on insulin syringe |
| Vials per cycle | 2 × 20 mg (40 days each); 4 × 10 mg or 1 × 40 mg equivalent |
| Storage | Refrigerate, use within 28 days |
Community-reported standard protocol: 500 mcg total daily (5 units) in the morning for 8 weeks. For localized injuries, community protocols describe injecting near the target area, providing local BPC-157 concentration alongside systemic TB-500 coverage.
Cycling Details
The standard cycle is 8 weeks on, 8 weeks off (or 4 weeks off minimum). Healing effects continue during the off period as tissue remodeling processes complete. Community sources commonly describe continued improvement for 2–4 weeks after stopping.
Loading protocol (aggressive): 750 mcg/day for 4 weeks, then 500 mcg/day for 8 weeks = 12 weeks total. For chronic injuries that haven't responded to standard dosing.
Twice-daily acute protocol: 500 mcg AM + 500 mcg PM (1,000 mcg total/day) for 4 weeks, then standard 500 mcg/day. For first 4 weeks post-surgery or acute injuries where speed matters. Community sources describe twice-daily dosing as beneficial for acute protocols given BPC-157's short half-life.
Routes of Administration
Subcutaneous (standard): For localized injuries, community protocols describe injecting near the target area. For systemic recovery, rotate between standard sites (abdomen, thigh, upper arm). TB-500 works systemically regardless of site; BPC-157 achieves higher local concentrations when injected nearby.
Injection sites: Lower abdomen (2 inches from navel), front of thigh, back of upper arm. Community injection protocols describe rotating sites to minimize lipodystrophy risk.
Reconstitution Quick Reference
Three vial sizes are sold. Scaling the water with the vial holds every one of them at the same 10 mg/mL, so the draw stays 5 units regardless of which size is on hand — only the days per vial change.
| Vial Size | BAC Water | Concentration | 500 mcg Dose | 750 mcg Dose | Days per Vial |
|---|---|---|---|---|---|
| 10 mg (5/5) | 1 mL | 10 mg/mL | 5 units | 7.5 units | 20 days |
| 20 mg (10/10) | 2 mL | 10 mg/mL | 5 units | 7.5 units | 40 days |
| 40 mg (20/20) | 4 mL | 10 mg/mL | 5 units | 7.5 units | 80 days |
At 10 mg/mL (10,000 mcg/mL) each unit on a U-100 insulin syringe carries 100 mcg of total blend, so a 500 mcg dose is 5 units. The 20 mg "10/10" vial is the most widely stocked; the 10 mg "5/5" and 40 mg "20/20" configurations are also carried by several vendors.
Community protocols describe swirling gently rather than shaking to preserve peptide integrity, with refrigeration at 2-8°C and use within 28 days. For the full step-by-step walkthrough, see the Wolverine Stack Reconstitution Guide.
